Frederic Champavere joins Triana as Managing Partner Europe
Frederic brings to Triana over thirty years experience in the pharmaceutical industry in various positions including diverse geographical responsibilities (both single and multi country), functional (at Corporate Head Office in the USA), operational and entrepreneurial as well as his charismatic leadership. Prior to joining Triana, Frederic was President of the French pharmaceutical company Negma following the acquisition by the Wockhardt Group of India and held responsabilities for continental Europe. Prior to that, he founded Pharma Omnium for which he raised €100 million with the investment fund Weinberg Capital Partners and acquired Biodim. Before going to the venture world, Frederic had an extensive experience with Big Pharma as he started his career at Eli Lilly & Company and over 18 years held several management positions in France, Europe and in the USA and drove Prozac success into the French market as President of Eli Lilly France. He then served as President of Janssen-Cilag France, the main affiliate of Johnson and Johnson in France. During this tenure, Frederic also served for several years as President of Agipharm, the French Local American Working Group. Frederic is a graduate from Science-Po in Paris where he also completed his Masters in Economics and Finance.